Increasing patient awareness of ketoacidosis with gliflozins-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Increasing patient awareness of ketoacidosis with gliflozins

Published:2024-05 Issue:3 Volume:35 Page:37-38
ISSN:0959-6682
Container-title:Prescriber
language:en
Short-container-title:Prescriber

Author:

Thompson Angus¹

Affiliation:

1. Angus Thompson is a former UK Primary Care Prescribing Advisor, now working in Australia as a Consulting Clinical Pharmacist conducting Home Medicines Reviews; Pharmacist Clinical Editor for Primary Health Tasmania; Lecturer in Therapeutics and Pharmacy Practice at the University of Tasmania; and occasional Subject Matter Expert for the Australian Pharmacy Council

Abstract

While SGLT2 inhibitors are generally well tolerated, their use has been associated with cases of ketoacidosis. It is therefore important to make patients aware of what steps they can take to minimise the risk of this potentially serious adverse effect.

Publisher

Wiley

Reference6 articles.

1. Open Prescribing. Available at:https://openprescribing.net

2. Dapagliflozin in heart failure with mildly reduced or preserved ejection fraction;Solomon SD;N Engl J Med,2022

3. Empagliflozin in heart failure with a preserved ejection fraction;Anker SD;N Engl J Med,2021

4. Diabetic ketoacidosis with SGLT2 inhibitors;Musso G;BMJ,2020

5. SGLT2 inhibitor‐induced ketoacidosis in a patient without diabetes;Hayes AG;Diabetes Care,2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP